DeCoach Rehabilitation Centre
-
Services:
- SAMHSA certification for opioid treatment program (OTP)
- State Substance use treatment agency
- State mental health department
- Commission on Accreditation of Rehabilitation Facilities (CARF)
- Drug Enforcement Agency (DEA)
- Smoking permitted in designated area
- Naloxone and overdose education
- Outcome follow-up after discharge
- Discharge Planning
- Aftercare/continuing care
- Payment assistance (check with facility for details)
- Sliding fee scale (fee is based on income and other factors)
- Buprenorphine with naloxone
- Non-nicotine smoking/tobacco cessation
- Clonidine
- Medication for mental disorders
- Lofexidine
- Disulfiram
- Nicotine replacement
- Naltrexone (oral)
- Acamprosate (CampralĀ®)
- Naltrexone (extended-release, injectable)
- Social skills development
- Integrated primary care services
- Suicide prevention services
- Mental health services
- Transportation assistance
- Case management service
- Clients with co-occurring mental and substance use disorders
- Active duty military
- Seniors or older adults
- Members of military families
- Pregnant/postpartum women
- Clients with co-occurring pain and substance use disorders
- Clients who have experienced sexual abuse
- Adult women
- Adult men
- Clients who have experienced trauma
- Clients with HIV or AIDS
- Clients who have experienced intimate partner violence, domestic violence
- Young adults
- Criminal justice (other than DUI/DWI)/Forensic clients
- Veterans
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Vaping permitted in designated area
- Assistance with obtaining social services
- Recovery coach
- Mentoring/peer support
- Self-help groups
- Employment counseling or training
- Housing services
- Sign language services for the deaf and hard of hearing
- Medication routinely used during detoxification
- Alcohol Detoxification
- Opioids detoxification
- Cocaine Detoxification
- Methamphetamines detoxification
- Benzodiazepines Detoxification
- In-network prescribing entity
- No formal relationship with prescribing entity
- Other contracted prescribing entity
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Detoxification
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- Transitional housing, halfway house, or sober home
- Outpatient day treatment or partial hospitalization
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient detoxification
- Intensive outpatient treatment
- Regular outpatient treatment
- Outpatient
- Hepatitis B (HBV) vaccination
- Hepatitis A (HAV) vaccination
- Private for-profit organization
- Federal military insurance (e.g., TRICARE)
- SAMHSA funding/block grants
- Medicaid
- Cash or self-payment
- Medicare
- Federal, or any government funding for substance use treatment programs
- State-financed health insurance plan other than Medicaid
- Private health insurance
- Smoking/vaping/tobacco cessation counseling
- Substance use disorder education
- Group counseling
- Health education services other than HIV/AIDS or hepatitis
- Marital/couples counseling
- Hepatitis education, counseling, or support
- Individual counseling
- HIV or AIDS education, counseling, or support
- Vocational training or educational support (for example, high school coursework, GED preparation, etc.)
- Family counseling
- Male
- Female
- Contingency management/motivational incentives
- Anger management
- Motivational interviewing
- Trauma-related counseling
- Matrix Model
- Telemedicine/telehealth therapy
- Brief intervention
- 12-step facilitation
- Community reinforcement plus vouchers
- Relapse prevention
- Substance use disorder counseling
- Cognitive behavioral therapy
- Screening for substance use
- Complete medical history/physical exam
- Comprehensive substance use assessment
- Outreach to persons in the community
- Screening for mental disorders
- Interim services for clients
- Screening for tobacco use
- Comprehensive mental health assessment
- Young Adults
- Adults
- No formal relationship with prescribing entity
- In-network prescribing entity
- Other contracted prescribing entity
- Metabolic syndrome monitoring
- Testing for Hepatitis C (HCV)
- Breathalyzer or blood alcohol testing
- Drug and alcohol oral fluid testing
- TB screening
- Drug or alcohol urine screening
- STD testing
- Testing for Hepatitis B (HBV)
- HIV testing
- Treatment for gambling disorder
- Treatment for other addiction disorder
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Buprenorphine maintenance
- Prescribes buprenorphine
- Prescribes naltrexone
- Relapse prevention with naltrexone
- Buprenorphine detoxification
- Maintenance service with medically supervised withdrawal after stabilization
- Accepts clients using MAT but prescribed elsewhere
- Lofexidine or Clonidine detoxification
- Federally-certified Opioid Treatment Program
License/Certification/Accreditation
Facility Smoking Policy
Transitional Services
Payment Assistance Available
Pharmacotherapies
Ancillary Services
Special Programs/Groups Offered
Facility Vaping Policy
Recovery Support Services
Language Services
Detoxification (medical withdrawal) Services
External Opioid Medications Source
Opioid Medications used in Treatment
Type of Care
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Medical Services
Facility Operation (e.g., Private, Public)
Payment/Insurance/Funding Accepted
Education and Counseling Services
Gender Accepted
Treatment Approaches
Assessment/Pre-treatment
Age Groups Accepted
External Source of Medications Used for Alcohol Use Disorder Treatment
Testing
Other Services
Type of Alcohol Use Disorder Treatment
Type of Opioid Treatment